Jialiang Liang

My primary research aims to develop novel therapeutic approaches (including gene-based or cell-based methods) for treating ischemic heart disease. Specifically, I focus on regenerating cardiomyocytes and vascular cells through engineering stem/progenitor cells or direct cellular reprogramming. Additionally, I investigate the molecular and epigenetic mechanisms of cell fate conversion using next-generation sequencing techniques.

PhD: Southern Medical University Guangzhou, China,

2018 -2022 Research Scientist, Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, OH

2022 -To Present Research Assistant Professor, Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, OH

Grant: #15POST25150010 Investigators:Liang, Jialiang 07-01-2015 -06-30-2016 American Heart Association - Great Rivers Affiliate The role of tunneling nanotubes in human iPSC-derived endothelial cells in angiogenesis of the infarcted heart Role:PI $45,000.00 Awarded Level:Private Non-Profit

Grant: #18CDA34110223 Investigators:Liang, Jialiang 07-01-2018 -06-30-2021 American Heart Association - National Chapter Conversion of fibroblasts into cardiovascular progenitors using CRISPR technology for heart regeneration Role:PI $77,000.00 Active Level:Private Non-Profit

Grant: #R01HL157456 Investigators:Fan, Guochang; Liang, Jialiang; Wang, Hongsheng; Wang, Yi-Gang 04-01-2021 -03-31-2025 National Heart, Lung and Blood Institute CRISPR-induced cardiovascular progenitor cells to repair myocardial infarction Role:multi-PI $623,215.00

Grant: #AHA 968781 Investigators:Liang, Jialiang 07-01-2022 -06-30-2025 American Heart Association - National Chapter In vivo rewiring a fibrosis pathway for therapeutic cardiac reprogramming Role:PI 100000.00 Awarded Level:Non Profit

Peer Reviewed Publications

Jiang, Lin; Liang, Jialiang; Huang, Wei; Ma, Jianyong; Park, Ki Ho; Wu, Zhichao; Chen, Peng; Zhu, Hua; Ma, Jian-Jie; Cai, Wenfeng; Paul, Christian; Niu, Liang; Fan, Guo-Chang; Wang, Hong-Sheng; Kanisicak, Onur; Xu, Meifeng; Wang, Yigang (2022. ) CRISPR activation of endogenous genes reprograms fibroblasts into cardiovascular progenitor cells for myocardial infarction therapy.Molecular therapy : the journal of the American Society of Gene Therapy, , 30 (1 ) ,54-74 More Information

Wu, Zhichao; Liang, Jialiang; Huang, Wei; Jiang, Lin; Paul, Christian; Lin, Bonnie; Zheng, Junmeng; Wang, Yigang (2021. ) Prompt Graft Cooling Enhances Cardioprotection during Heart Transplantation Procedures through the Regulation of Mitophagy.Cells, , 10 (11 ) , More Information

Wu, Zhichao; Liang, Jialiang; Huang, Wei; Jiang, Lin; Paul, Christian; Gao, Xiang; Alam, Perwez; Kanisicak, Onur; Xu, Meifeng; Wang, Yigang (2021. ) Immunomodulatory effects of mesenchymal stem cells for the treatment of cardiac allograft rejection.Experimental biology and medicine (Maywood, N.J.), , 246 (7 ) ,851-860 More Information

Jiang, Lin; Liang, Jialiang; Huang, Wei; Wu, Zhichao; Paul, Christian; Wang, Yigang (2020. ) Strategies and Challenges to Improve Cellular Programming-Based Approaches for Heart Regeneration Therapy.International journal of molecular sciences, , 21 (20 ) , More Information

Liang, Jialiang; Huang, Wei; Jiang, Lin; Paul, Christian; Li, Xiangnan; Wang, Yigang (2019. ) Concise Review: Reduction of Adverse Cardiac Scarring Facilitates Pluripotent Stem Cell-Based Therapy for Myocardial Infarction.Stem cells (Dayton, Ohio), , 37 (7 ) ,844-854 More Information

Huang, Wei; Liang, Jialiang; Feng, Yuliang; Jia, Zhanfeng; Jiang, Lin; Cai, Wenfeng; Paul, Christian; Gu, Jianguo G; Stambrook, Peter J; Millard, Ronald W; Zhu, Xiao-Lan; Zhu, Ping; Wang, Yigang (2018. ) Heterogeneity of adult masseter muscle satellite cells with cardiomyocyte differentiation potential.Experimental cell research, , 371 (1 ) ,20-30 More Information

Huang, Wei; Feng, Yuliang; Liang, Jialiang; Yu, Hao; Wang, Cheng; Wang, Boyu; Wang, Mingyang; Jiang, Lin; Meng, Wei; Cai, Wenfeng; Medvedovic, Mario; Chen, Jenny; Paul, Christian; Davidson, W Sean; Sadayappan, Sakthivel; Stambrook, Peter J; Yu, Xi-Yong; Wang, Yigang (2018. ) Loss of microRNA-128 promotes cardiomyocyte proliferation and heart regeneration.Nature communications, , 9 (1 ) ,700 More Information

Ma, Ruilian; Liang, Jialiang; Huang, Wei; Guo, Linlin; Cai, Wenfeng; Wang, Lei; Paul, Christian; Yang, Huang-Tian; Kim, Ha Won; Wang, Yigang (2018. ) Electrical Stimulation Enhances Cardiac Differentiation of Human Induced Pluripotent Stem Cells for Myocardial Infarction Therapy.Antioxidants & redox signaling, , 28 (5 ) ,371-384 More Information

Liang, Jialiang; Huang, Wei; Cai, Wenfeng; Wang, Lei; Guo, Linlin; Paul, Christian; Yu, Xi-Yong; Wang, Yigang (2017. ) Inhibition of microRNA-495 Enhances Therapeutic Angiogenesis of Human Induced Pluripotent Stem Cells.Stem cells (Dayton, Ohio), , 35 (2 ) ,337-350 More Information

Liang, Jialiang; Huang, Wei; Yu, Xiyong; Ashraf, Atif; Wary, Kishore K; Xu, Meifeng; Millard, Ronald W; Ashraf, Muhammad; Wang, Yigang (2012. ) Suicide gene reveals the myocardial neovascularization role of mesenchymal stem cells overexpressing CXCR4 (MSC(CXCR4)).PloS one, , 7 (9 ) ,e46158 More Information

Wu, Zhichao; Huang, Wei; He, Xingyu; Dutta, Suchandrima; Paul, Christian; Fan, Guo-Chang; Kanisicak, Onur; Xu, Meifeng; Liang, Jialiang; Wang, Yigang (2023. ) Myocardial IGF2R is a critical mediator of inflammation and fibrosis after ischemia-reperfusion injury.bioRxiv : the preprint server for biology, , More Information

He, Xingyu; Liang, Jialiang; Paul, Christian; Huang, Wei; Dutta, Suchandrima; Wang, Yigang (2022. ) Advances in Cellular Reprogramming-Based Approaches for Heart Regenerative Repair.Cells, , 11 (23 ) , More Information

Cai, Wen-Feng; Kang, Kai; Huang, Wei; Liang, Jia-Liang; Feng, Yu-Liang; Liu, Guan-Sheng; Chang, De-Hua; Wen, Zhi-Li; Paul, Christian; Xu, Meifeng; Millard, Ronald W; Wang, Yigang (2015. ) CXCR4 attenuates cardiomyocytes mitochondrial dysfunction to resist ischaemia-reperfusion injury.Journal of cellular and molecular medicine, , 19 (8 ) ,1825-35 More Information

Yu, Xi-Yong; Geng, Yong-Jian; Liang, Jia-Liang; Zhang, Saidan; Lei, He-Ping; Zhong, Shi-Long; Lin, Qiu-Xiong; Shan, Zhi-Xin; Lin, Shu-Guang; Li, Yangxin (2012. ) High levels of glucose induce "metabolic memory" in cardiomyocyte via epigenetic histone H3 lysine 9 methylation.Molecular biology reports, , 39 (9 ) ,8891-8 More Information

Liang, Jia-Liang; Feng, Zhi-Kuan; Liu, Xiao-Ying; Lin, Qiu-Xiong; Fu, Yong-Heng; Shan, Zhi-Xin; Zhu, Jie-Ning; Lin, Shu-Guang; Yu, Xi-Yong (2011. ) Effect of impaired glucose tolerance on cardiac dysfunction in a rat model of prediabetes. Chinese medical journal, , 124 (5 ) ,734-9

Yu, Xi-Yong; Chen, Hong-Mei; Liang, Jia-Liang; Lin, Qiu-Xiong; Tan, Hong-Hong; Fu, Yong-Heng; Liu, Xiao-Ying; Shan, Zhi-Xin; Li, Xiao-Hong; Yang, Hua-Zhang; Yang, Min; Li, Yangxin; Lin, Shu-Guang (2011. ) Hyperglycemic myocardial damage is mediated by proinflammatory cytokine: macrophage migration inhibitory factor.PloS one, , 6 (1 ) ,e16239 More Information

Yu, Xi-Yong; Geng, Yong-Jian; Liang, Jia-Liang; Lin, Qiu-Xiong; Lin, Shu-Guang; Zhang, Saidan; Li, Yangxin (2010. ) High levels of glucose induce apoptosis in cardiomyocyte via epigenetic regulation of the insulin-like growth factor receptor.Experimental cell research, , 316 (17 ) ,2903-9 More Information

Liang, Jia-Liang; Xiao, Ding-Zhang; Liu, Xiao-Ying; Lin, Qiu-Xiong; Shan, Zhi-Xin; Zhu, Jie-Ning; Lin, Shu-Guang; Yu, Xi-Yong (2010. ) High glucose induces apoptosis in AC16 human cardiomyocytes via macrophage migration inhibitory factor and c-Jun N-terminal kinase.Clinical and experimental pharmacology & physiology, , 37 (10 ) ,969-73 More Information

He, Xingyu; Dutta, Suchandrima; Liang, Jialiang; Paul, Christian; Huang, Wei; Xu, Meifeng; Chang, Vivian; Wang, Yigang (2023. ) Direct Cellular Reprogramming Techniques for Cardiovascular Regenerative Therapeutics.Canadian journal of physiology and pharmacology, , More Information

Park, Ki Ho; He, Xingyu; Jiang, Lin; Zhu, Hua; Liang, Jialiang; Wang, Yigang; Ma, Jianjie (2023. ) Activation of MG53 Enhances Cell Survival and Engraftment of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Injured Hearts.Stem cell reviews and reports, , 19 (7 ) ,2420-2428 More Information

Research - CVC 1960